Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Amgen, Obesity
What's Next for Amgen Obesity Drug After Investors Disappointed by Results
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.
Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark
Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound.
A scrap of data on Amgen’s obesity drug candidate wipes out $12 billion in market value
On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value.
Biden, obesity and Medicare
Biden administration proposes expanding obesity drug coverage under Medicare and Medicaid
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.
Biden proposes anti-obesity drug rule
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Biden proposes Medicaid, Medicare cover obesity drugsA proposed rule from the Biden administration
Pharmalittle: We’re reading about Medicare obesity drug coverage, a first-of-its-kind 340B analysis, and more
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound
6h
on MSN
Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
McKnight's Long-Term Care News
18h
CMS’ obesity drug coverage implications for nursing home patients
A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...
Yahoo
1d
Doctor says Biden's weight-loss drug proposal is a "formal recognition" that obesity is an illness
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare ...
9h
on MSN
Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
STAT
3d
Pharmalittle: We’re reading about Trump’s FDA pick, problems with a Merck asthma drug, and more
Martin Makary, President-elect Trump’s pick to run the U.S. Food and
Drug
Administration ... in the middle of a fight ...
Yahoo
6d
Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular
obesity
drug
Wegovy in China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
MariTide
Joe Biden
Medicaid
Feedback